...
首页> 外文期刊>Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment >Detection of corona enhancement of hypervascular hepatocellular carcinoma by C-arm dual-phase cone-beam CT during hepatic arteriography.
【24h】

Detection of corona enhancement of hypervascular hepatocellular carcinoma by C-arm dual-phase cone-beam CT during hepatic arteriography.

机译:C臂双相锥形束CT在肝动脉造影期间检测电晕增强的高血管性肝细胞癌。

获取原文
获取原文并翻译 | 示例

摘要

The purpose of this study was to evaluate the detectability of corona enhancement around the hypervascular hepatocellular carcinoma (HCC) by dual-phase cone-beam computed tomography during hepatic arteriography (CBCTHA). Dual-phase CBCTHA was performed for 71 HCC lesions (mean +/- SD 1.7 +/- 0.9 cm), including seven presenting a nodule-in-nodule appearance and nine hypervascular pseudolesions. The first scan was performed during injection of 30-40 ml half-diluted contrast material at a rate of 1.5-2 ml/s through the hepatic artery. Scanning was initiated 7 s after the beginning of contrast material injection. The second scan was started 30 s after the end of the first scan. Detectability of corona enhancement on second-phase CBCTHA was evaluated. Thickness of corona enhancement was also analyzed as thin (2 mm). Corona enhancement was detected in 63 (88.7%) of 71 tumors (1.8 +/- 0.9 cm), but it was not detected in eight tumors (1.0 +/- 0.2 cm). Thin corona enhancement was seen in 18 tumors (1.2 +/- 0.5 cm), and thick corona enhancement was seen in 45 tumors (2.0 +/- 0.9 cm). There was a significant difference in tumor diameter between tumors with and those without corona enhancement (P = 0.0157) and between thin and thick corona enhancement (P = 0.001). In all seven early-stage tumors, corona enhancement was demonstrated around the hypervascular focus within the hypovascular tumor portion. None of the nine pseudolesions showed any corona enhancement. Dual-phase CBCTHA depicted corona enhancement in 88.7% of hypervascular HCC lesions. This technique may improve the diagnostic accuracy of HCC.
机译:这项研究的目的是通过肝动脉造影(CBCTHA)中的双相锥形束计算机断层扫描技术评估在高血管性肝细胞癌(HCC)周围电晕增强的可检测性。对71例HCC病变(平均+/- SD 1.7 +/- 0.9 cm)进行了双相CBCTHA治疗,包括7例出现结节状结节和9例血管增生假性病变。第一次扫描是在以1.5-2 ml / s的速度通过肝动脉注射30-40 ml半稀释的对比剂期间进行的。开始注入造影剂后7秒钟开始扫描。第二次扫描在第一次扫描结束30秒后开始。评估了第二相CBCTHA上电晕增强的可检测性。还分析了电晕增强的厚度为薄( 2 mm)。在71个肿瘤(1.8 +/- 0.9 cm)中的63个(88.7%)中检测到电晕增强,但在八个肿瘤(1.0 +/- 0.2 cm)中未检测到电晕增强。在18个肿瘤(1.2 +/- 0.5厘米)中观察到了薄的电晕增强,在45个肿瘤(2.0 +/- 0.9厘米)中看到了较厚的电晕增强。有和没有电晕增强的肿瘤之间的肿瘤直径存在显着差异(P = 0.0157),而有薄和厚的电晕增强之间的肿瘤直径(P = 0.001)。在所有七个早期肿瘤中,在血管下肿瘤部分内的高血管灶周围均表现出电晕增强。九个假病变均未显示出任何电晕增强。双相CBCTHA显示88.7%的高血管HCC病变的电晕增强。此技术可以提高HCC的诊断准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号